Pioglitazone 45 MG Oral Tablet — RxCUI 312441
RxNorm drug concept · Semantic clinical drug
RxCUI 312441
Semantic clinical drug · SCD
● Current RxNorm concept 40 FDA products
116 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI312441
Official namePioglitazone 45 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspioglitazone (as pioglitazone HCl) 45 MG Oral Tablet
FDA products mapped40
Package NDCs mapped116
Reported Medicaid activity (SDUD)511,105 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Pioglitazone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It helps lower blood sugar in adults with type 2 diabetes, along with diet and exercise. It works by helping your body use its own insulin better. It is not for type 1 diabetes or...
- Take it by mouth once a day. Food doesn't matter, so take it whenever is easiest to remember. Follow your prescriber's directions and the pharmacy label.
- Colds, headache, sinus trouble, muscle aches and a sore throat are common. Some swelling and weight gain can happen too. Call me or your doctor right away about fast weight gain, s...
- What side effects are normal, and what should I call about?
🕸️ Concept Web — How Pioglitazone 45 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Pioglitazone 45 MG Oral Tablet
RxCUI 312441 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Pioglitazone
33738IN
-
Pioglitazone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Actos
261442BN
-
Actos
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Pioglitazone Oral Tablet
374606SCDF -
Pioglitazone Oral Product
1163231SCDG -
Pioglitazone Pill
1163232SCDG -
Pioglitazone Oral Tablet [Actos]
368230SBDF -
Actos Oral Product
1169928SBDG -
Actos Pill
1169929SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Pioglitazone Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Pioglitazone 45 MG
332436SCDC -
Pioglitazone 45 MG Oral Tablet [Actos]
261268SBD -
Pioglitazone 45 MG [Actos]
574497SBDC
-
Pioglitazone 45 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Pioglitazone 45 MG
SCDC · 332436 -
Pioglitazone Oral Tablet
SCDF · 374606 -
Pioglitazone Oral Product
SCDG · 1163231 -
Pioglitazone Pill
SCDG · 1163232
Brand-Name Concepts
-
Pioglitazone 45 MG Oral Tablet [Actos]
SBD · 261268 -
Pioglitazone 45 MG [Actos]
SBDC · 574497 -
Pioglitazone Oral Tablet [Actos]
SBDF · 368230 -
Actos Oral Product
SBDG · 1169928 -
Actos Pill
SBDG · 1169929 -
Actos
BN · 261442
📦 FDA Products & Package NDCs
40 products · 116 package NDCs
116 package NDCs map to RxCUI 312441 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-7271-05 | 500 TABLET in 1 BOTTLE (0093-7271-05) | Pioglitazone | Teva Pharmaceuticals USA, Inc. | 2015-02-04 |
| 00093-7271-56 | 30 TABLET in 1 BOTTLE (0093-7271-56) | Pioglitazone | Teva Pharmaceuticals USA, Inc. | 2015-06-03 |
| 00093-7271-98 | 90 TABLET in 1 BOTTLE (0093-7271-98) | Pioglitazone | Teva Pharmaceuticals USA, Inc. | 2015-05-13 |
| 00093-7272-05 | 500 TABLET in 1 BOTTLE (0093-7272-05) | Pioglitazone | Teva Pharmaceuticals USA, Inc. | 2015-02-04 |
| 00093-7272-56 | 30 TABLET in 1 BOTTLE (0093-7272-56) | Pioglitazone | Teva Pharmaceuticals USA, Inc. | 2015-04-22 |
| 00093-7272-98 | 90 TABLET in 1 BOTTLE (0093-7272-98) | Pioglitazone | Teva Pharmaceuticals USA, Inc. | 2015-06-03 |
| 00093-7273-05 | 500 TABLET in 1 BOTTLE (0093-7273-05) | Pioglitazone | Teva Pharmaceuticals USA, Inc. | 2015-05-22 |
| 00093-7273-56 | 30 TABLET in 1 BOTTLE (0093-7273-56) | Pioglitazone | Teva Pharmaceuticals USA, Inc. | 2015-09-29 |
| 00093-7273-98 | 90 TABLET in 1 BOTTLE (0093-7273-98) | Pioglitazone | Teva Pharmaceuticals USA, Inc. | 2015-07-28 |
| 16714-0645-01 | 30 TABLET in 1 BOTTLE (16714-645-01) | Pioglitazone | NorthStar RxLLC | 2022-08-18 |
| 16714-0645-02 | 90 TABLET in 1 BOTTLE (16714-645-02) | Pioglitazone | NorthStar RxLLC | 2022-08-18 |
| 16714-0645-03 | 500 TABLET in 1 BOTTLE (16714-645-03) | Pioglitazone | NorthStar RxLLC | 2022-08-18 |
| 16714-0646-01 | 30 TABLET in 1 BOTTLE (16714-646-01) | Pioglitazone | NorthStar RxLLC | 2022-08-18 |
| 16714-0646-02 | 90 TABLET in 1 BOTTLE (16714-646-02) | Pioglitazone | NorthStar RxLLC | 2022-08-18 |
| 16714-0646-03 | 500 TABLET in 1 BOTTLE (16714-646-03) | Pioglitazone | NorthStar RxLLC | 2022-08-18 |
| 16714-0647-01 | 30 TABLET in 1 BOTTLE (16714-647-01) | Pioglitazone | NorthStar RxLLC | 2022-08-18 |
| 16714-0647-02 | 90 TABLET in 1 BOTTLE (16714-647-02) | Pioglitazone | NorthStar RxLLC | 2022-08-18 |
| 16714-0647-03 | 500 TABLET in 1 BOTTLE (16714-647-03) | Pioglitazone | NorthStar RxLLC | 2022-08-18 |
| 33342-0054-07 | 30 TABLET in 1 BOTTLE (33342-054-07) | Pioglitazone | Macleods Pharmaceuticals Limited | 2013-02-14 |
| 33342-0054-10 | 90 TABLET in 1 BOTTLE (33342-054-10) | Pioglitazone | Macleods Pharmaceuticals Limited | 2013-02-14 |
| 33342-0054-12 | 100 TABLET in 1 BOX, UNIT-DOSE (33342-054-12) | Pioglitazone | Macleods Pharmaceuticals Limited | 2013-02-14 |
| 33342-0054-15 | 500 TABLET in 1 BOTTLE (33342-054-15) | Pioglitazone | Macleods Pharmaceuticals Limited | 2013-02-14 |
| 33342-0055-07 | 30 TABLET in 1 BOTTLE (33342-055-07) | Pioglitazone | Macleods Pharmaceuticals Limited | 2013-02-14 |
| 33342-0055-10 | 90 TABLET in 1 BOTTLE (33342-055-10) | Pioglitazone | Macleods Pharmaceuticals Limited | 2013-02-14 |
| 33342-0055-12 | 100 TABLET in 1 BOX, UNIT-DOSE (33342-055-12) | Pioglitazone | Macleods Pharmaceuticals Limited | 2013-02-14 |
| 33342-0055-15 | 500 TABLET in 1 BOTTLE (33342-055-15) | Pioglitazone | Macleods Pharmaceuticals Limited | 2013-02-14 |
| 33342-0056-07 | 30 TABLET in 1 BOTTLE (33342-056-07) | Pioglitazone | Macleods Pharmaceuticals Limited | 2013-02-14 |
| 33342-0056-10 | 90 TABLET in 1 BOTTLE (33342-056-10) | Pioglitazone | Macleods Pharmaceuticals Limited | 2013-02-14 |
| 33342-0056-12 | 100 TABLET in 1 BOX, UNIT-DOSE (33342-056-12) | Pioglitazone | Macleods Pharmaceuticals Limited | 2013-02-14 |
| 33342-0056-15 | 500 TABLET in 1 BOTTLE (33342-056-15) | Pioglitazone | Macleods Pharmaceuticals Limited | 2013-02-14 |
| 42291-0959-30 | 30 TABLET in 1 BOTTLE (42291-959-30) | Pioglitazone | AvKARE | 2024-09-17 |
| 42291-0959-90 | 90 TABLET in 1 BOTTLE (42291-959-90) | Pioglitazone | AvKARE | 2024-09-17 |
| 42291-0960-30 | 30 TABLET in 1 BOTTLE (42291-960-30) | Pioglitazone | AvKARE | 2024-09-17 |
| 42291-0960-90 | 90 TABLET in 1 BOTTLE (42291-960-90) | Pioglitazone | AvKARE | 2024-09-17 |
| 42291-0961-30 | 30 TABLET in 1 BOTTLE (42291-961-30) | Pioglitazone | AvKARE | 2024-09-17 |
| 42291-0961-50 | 500 TABLET in 1 BOTTLE (42291-961-50) | Pioglitazone | AvKARE | 2024-09-17 |
| 43547-0426-03 | 30 TABLET in 1 BOTTLE (43547-426-03) | PIOGLITAZONE | Solco Healthcare LLC | 2018-05-20 |
| 43547-0426-09 | 90 TABLET in 1 BOTTLE (43547-426-09) | PIOGLITAZONE | Solco Healthcare LLC | 2018-05-20 |
| 43547-0426-50 | 500 TABLET in 1 BOTTLE (43547-426-50) | PIOGLITAZONE | Solco Healthcare LLC | 2018-05-20 |
| 43547-0427-03 | 30 TABLET in 1 BOTTLE (43547-427-03) | PIOGLITAZONE | Solco Healthcare LLC | 2018-05-20 |
| 43547-0427-09 | 90 TABLET in 1 BOTTLE (43547-427-09) | PIOGLITAZONE | Solco Healthcare LLC | 2018-05-20 |
| 43547-0427-50 | 500 TABLET in 1 BOTTLE (43547-427-50) | PIOGLITAZONE | Solco Healthcare LLC | 2018-05-20 |
| 43547-0428-03 | 30 TABLET in 1 BOTTLE (43547-428-03) | PIOGLITAZONE | Solco Healthcare LLC | 2018-05-20 |
| 43547-0428-09 | 90 TABLET in 1 BOTTLE (43547-428-09) | PIOGLITAZONE | Solco Healthcare LLC | 2018-05-20 |
| 43547-0428-50 | 500 TABLET in 1 BOTTLE (43547-428-50) | PIOGLITAZONE | Solco Healthcare LLC | 2018-05-20 |
| 50090-6384-00 | 30 TABLET in 1 BOTTLE (50090-6384-0) | PIOGLITAZONE HYDROCHLORIDE | A-S Medication Solutions | 2023-03-03 |
| 50090-6384-01 | 90 TABLET in 1 BOTTLE (50090-6384-1) | PIOGLITAZONE HYDROCHLORIDE | A-S Medication Solutions | 2023-03-03 |
| 50090-6412-00 | 30 TABLET in 1 BOTTLE (50090-6412-0) | Pioglitazone | A-S Medication Solutions | 2023-03-28 |
| 50090-6412-01 | 90 TABLET in 1 BOTTLE (50090-6412-1) | Pioglitazone | A-S Medication Solutions | 2023-03-28 |
| 57237-0219-05 | 500 TABLET in 1 BOTTLE (57237-219-05) | Pioglitazone | Rising Pharma Holdings, Inc. | 2013-02-13 |
Observed labelers:
Aurobindo Pharma Limited (12) ·
Macleods Pharmaceuticals Limited (12) ·
Takeda Pharmaceuticals America, Inc. (12) ·
Unichem Pharmaceuticals (USA), Inc. (12) ·
GSMS, Incorporated (9) ·
NorthStar RxLLC (9)
· +9 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.